2-Azaniumylacetate

Details

Top
Internal ID 111852f3-f158-4e6a-b4fd-183654c298b0
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Alpha amino acids
IUPAC Name 2-azaniumylacetate
SMILES (Canonical) C(C(=O)[O-])[NH3+]
SMILES (Isomeric) C(C(=O)[O-])[NH3+]
InChI InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
InChI Key DHMQDGOQFOQNFH-UHFFFAOYSA-N
Popularity 5,211 references in papers

Physical and Chemical Properties

Top
Molecular Formula C2H5NO2
Molecular Weight 75.07 g/mol
Exact Mass 75.032028402 g/mol
Topological Polar Surface Area (TPSA) 67.80 Ų
XlogP -2.80
Atomic LogP (AlogP) -3.02
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
alpha glycine
alpha-glycine
Gamma glycine
[3H]glycine
[14C]-glycine
127883-08-3
delta glycine
gamma-glycine
Epsilon glycine
Glycine beta
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 2-Azaniumylacetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9587 95.87%
Caco-2 - 0.6460 64.60%
Blood Brain Barrier + 0.8000 80.00%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Mitochondria 0.4983 49.83%
OATP2B1 inhibitior - 0.8678 86.78%
OATP1B1 inhibitior + 0.9528 95.28%
OATP1B3 inhibitior + 0.9559 95.59%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9559 95.59%
P-glycoprotein inhibitior - 0.9886 98.86%
P-glycoprotein substrate - 0.9928 99.28%
CYP3A4 substrate - 0.8064 80.64%
CYP2C9 substrate - 0.6170 61.70%
CYP2D6 substrate - 0.8436 84.36%
CYP3A4 inhibition - 0.9796 97.96%
CYP2C9 inhibition - 0.9299 92.99%
CYP2C19 inhibition - 0.9290 92.90%
CYP2D6 inhibition - 0.9431 94.31%
CYP1A2 inhibition - 0.7810 78.10%
CYP2C8 inhibition - 0.9949 99.49%
CYP inhibitory promiscuity - 0.9282 92.82%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) + 0.5354 53.54%
Carcinogenicity (trinary) Non-required 0.5979 59.79%
Eye corrosion + 0.9792 97.92%
Eye irritation + 0.9426 94.26%
Skin irritation + 0.6772 67.72%
Skin corrosion + 0.5619 56.19%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8495 84.95%
Micronuclear - 0.7841 78.41%
Hepatotoxicity + 0.6875 68.75%
skin sensitisation - 0.9448 94.48%
Respiratory toxicity - 0.7778 77.78%
Reproductive toxicity - 0.7000 70.00%
Mitochondrial toxicity - 0.5500 55.00%
Nephrotoxicity + 0.6071 60.71%
Acute Oral Toxicity (c) III 0.6053 60.53%
Estrogen receptor binding - 0.9567 95.67%
Androgen receptor binding - 0.9420 94.20%
Thyroid receptor binding - 0.9139 91.39%
Glucocorticoid receptor binding - 0.9314 93.14%
Aromatase binding - 0.9114 91.14%
PPAR gamma - 0.8822 88.22%
Honey bee toxicity - 0.9202 92.02%
Biodegradation + 0.9000 90.00%
Crustacea aquatic toxicity - 0.8500 85.00%
Fish aquatic toxicity - 0.9554 95.54%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.13% 96.09%
CHEMBL4040 P28482 MAP kinase ERK2 84.22% 83.82%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 83.33% 94.45%

Cross-Links

Top
PubChem 5257127
NPASS NPC126681
ChEMBL CHEMBL773